Recombinant Vibrio vulnificus UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase (murG)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Vibrio vulnificus UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine Transferase (MurG)

Vibrio vulnificus UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase, commonly known as MurG, is a vital enzyme involved in peptidoglycan biosynthesis in Vibrio vulnificus . MurG is a glycosyltransferase that catalyzes the transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol, a precursor of peptidoglycan . Peptidoglycan is essential for bacterial cell wall integrity, shape determination, adaptation to the environment, and cell division .

Role of MurG in Peptidoglycan Biosynthesis

MurG is crucial for synthesizing the bacterial cell wall, which maintains cellular integrity, determines cell shape and facilitates adaptation to the surrounding environment . The enzyme facilitates the formation of a glycosidic bond between N-acetylmuramyl pentapeptide and GlcNAc .

The steps in peptidoglycan biosynthesis are:

  1. Cytoplasmic Steps Includes the synthesis of UDP-N-acetylmuramoyl-pentapeptide precursors . Enzymes like MurA, MurB, MurC, MurD, MurE, and MurF participate in these steps .

  2. Membrane Steps Involves the transfer of UDP-N-acetylmuramoyl-pentapeptide to undecaprenyl phosphate and the subsequent addition of N-acetylglucosamine (catalyzed by MurG) . MraY and MurG are key enzymes in this phase .

  3. Periplasmic Steps Includes the polymerization of the peptidoglycan chains and their cross-linking . Penicillin-binding proteins (PBPs) are essential in this final stage .

Importance of MurG as an Antibacterial Target

The bacterial cell wall synthesis pathway, including MurG, is an attractive target for antibacterial compounds because it is essential for bacteria but absent in humans, reducing the risk of toxicity .

In vivo Essentiality of MurG in V. vulnificus

A study identified murG as an essential gene for the survival of V. vulnificus during wound infection . Mutation in murG affects cell morphology and rapid cell division, highlighting its importance in maintaining bacterial cell structure and proliferation .

Regulation of Gene Expression

The expression of genes related to virulence and cell survival in V. vulnificus, such as vvhA (encoding hemolysin), is influenced by various factors, including cAMP-CRP, iron levels, and environmental signals . Although murG itself was not mentioned in the context of these regulatory mechanisms, understanding how vvhA is regulated provides insight into the complex regulatory networks that govern bacterial pathogenesis .

Recombinant Expression and Characterization of Related Enzymes

A study on the glycogen branching enzyme (VvGBE) from V. vulnificus showed that recombinant expression in E. coli is feasible, with the enzyme exhibiting specific activity under certain conditions . This demonstrates the potential for producing recombinant enzymes from V. vulnificus for various applications .

Mur Enzymes in Other Bacteria

Other Mur enzymes, like MurE from Verrucomicrobium spinosum, have been characterized biochemically, showing their roles in peptidoglycan biosynthesis . These enzymes catalyze reactions in the cytoplasmic steps of peptidoglycan synthesis .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. Please specify your desired tag type for preferential development.
Synonyms
murG; VV0614; UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase; EC 2.4.1.227; Undecaprenyl-PP-MurNAc-pentapeptide-UDPGlcNAc GlcNAc transferase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-355
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Vibrio vulnificus (strain YJ016)
Target Names
murG
Target Protein Sequence
MKKNKRLMVM AGGTGGHVFP GLAVAKKLQQ QGWEIRWLGT ADRMEAELVP KHGIDIDFIK VKGLRGQGIK RLVLAPFQIL NAIFQAKAHI KRWQPDAVLG MGGYVSGPGG IAAWLSGIPV VLHEQNAVAG LTNHWLAKIA KKVFQAFPGA FKDAPVVGNP VREDVVALPD PMQRMQDREG AVRILVMGGS QGARILNQTM PQVMAQLGSG FEIRHQAGKG SADEVRLAYQ QVGVEHVEVS EFIDDVAAQY AWADLLVCRS GALTVSEVSA AGVGAIFIPF MHKDRQQALN ADHLVACGAA LMIEQPQLTV DKLAGEIQKL GRDTLLSMAL HARAAAQNNA DQVVADAIVA LTEQK
Uniprot No.

Target Background

Function

Function: Cell wall formation. This enzyme catalyzes the transfer of a GlcNAc subunit onto undecaprenyl-pyrophosphoryl-MurNAc-pentapeptide (lipid intermediate I) to produce undecaprenyl-pyrophosphoryl-MurNAc-(pentapeptide)GlcNAc (lipid intermediate II).

Database Links

KEGG: vvy:VV0614

Protein Families
Glycosyltransferase 28 family, MurG subfamily
Subcellular Location
Cell inner membrane; Peripheral membrane protein; Cytoplasmic side.

Q&A

What is the role of murG transferase in Vibrio vulnificus pathogenicity?

UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase (murG) is a critical enzyme in bacterial cell wall peptidoglycan biosynthesis. In Vibrio vulnificus, this enzyme catalyzes the transfer of N-acetylglucosamine to lipid-linked muramic acid during cell wall formation. While not directly a virulence factor like the MARTX toxin, murG functionality is essential for bacterial survival, affecting cell integrity and potentially antibiotic resistance. The enzyme's proper functioning ensures the bacterium can maintain cellular structure during infection processes. Research indicates that bacterial cell wall synthesis enzymes like murG can influence pathogenicity indirectly by affecting bacterial fitness in host environments, similar to how other factors in V. vulnificus contribute to its virulence potential in human hosts .

How does murG expression relate to other virulence factors in Vibrio vulnificus?

The expression of murG in Vibrio vulnificus operates within a complex regulatory network that includes known virulence factors. While murG itself is primarily involved in cell wall synthesis, its expression can be coordinated with virulence factors like the MARTX (multifunctional-autoprocessing RTX) toxin and VvhA hemolysin. During host infection, Vibrio vulnificus modulates expression of both structural proteins and virulence factors in response to environmental cues. The relationship between murG and virulence may be particularly relevant during infection progression, as bacterial replication (requiring murG for cell wall synthesis) must be coordinated with toxin production for successful tissue invasion. Unlike the rtxA1 gene that encodes the MARTX toxin and shows significant variation through recombination events, murG tends to be more conserved across strains, though expression levels may vary depending on growth conditions and infection stages .

How do genetic variations in murG compare to variations observed in rtxA1?

Unlike the rtxA1 gene which undergoes significant recombination generating multiple toxin variants with different effector domain arrangements, the murG gene in Vibrio vulnificus tends to be more conserved due to its essential role in cell wall biosynthesis. Research has shown that rtxA1 exhibits at least four distinct variants resulting from recombination with plasmid-carried rtxA genes or rtxA genes from other marine pathogens like Vibrio anguillarum . This genetic plasticity allows for the emergence of novel strains with potentially altered virulence. In contrast, murG typically shows less variation, with changes primarily observed in expression regulation rather than structural domains. When variations do occur in murG, they are generally more subtle than those seen in rtxA1 and may involve single nucleotide polymorphisms rather than large domain rearrangements. This difference in genetic stability reflects the distinct selective pressures on these genes - rtxA1 being subject to host immune pressure versus murG being constrained by its essential enzymatic function .

What considerations are important when designing experiments to study recombinant murG expression in Vibrio vulnificus?

When designing experiments to study recombinant murG expression in Vibrio vulnificus, researchers must carefully plan several critical elements. First, treatment randomization is essential to minimize bias, as emphasized in experimental design principles . For murG studies specifically, researchers should consider:

  • Expression system selection: Choose between homologous (V. vulnificus-based) or heterologous (E. coli-based) expression systems based on experimental goals

  • Induction conditions: Optimize temperature, inducer concentration, and timing to maximize functional protein yield

  • Proper controls: Include wild-type strains, empty vector controls, and inactive mutant versions

  • Environmental factors: Account for salinity, pH, and temperature relevant to V. vulnificus natural habitats

  • Sample size determination: Calculate required replicates based on expected effect sizes and statistical power needs

The experimental design should connect objectives to appropriate analytical methods. As noted in research design principles, researchers should "focus on connecting the objectives of research to the type of experimental design required, describing the actual process of creating the design and collecting the data, showing how to perform the proper analysis of the data, and illustrating the interpretation of results" . For murG studies, this means clearly defining whether the goal is functional characterization, expression pattern analysis, or interaction studies, then designing protocols specifically suited to those objectives.

What are the optimal conditions for expressing and purifying recombinant murG from Vibrio vulnificus?

Expressing and purifying recombinant murG from Vibrio vulnificus requires careful optimization of multiple parameters. The following table summarizes the key conditions that have proven effective in research settings:

ParameterOptimal ConditionsNotes
Expression SystemE. coli BL21(DE3)Provides good yield while minimizing toxicity
VectorpET-28a(+) with N-terminal His-tagFacilitates purification and detection
Induction0.5 mM IPTG at OD600 0.6-0.8Higher concentrations may lead to inclusion bodies
Temperature18°C post-inductionLower temperature improves folding
Induction Time16-18 hoursExtended time improves yield
Lysis Buffer50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol, 1 mM DTTProtects enzyme activity
PurificationNi-NTA affinity followed by size exclusionTwo-step process improves purity
Storage-80°C in 20% glycerolMaintains activity for >6 months

For functional studies, it's critical to verify enzyme activity immediately after purification. Similar to approaches used for studying other V. vulnificus proteins, researchers should assess protein integrity through SDS-PAGE and western blotting before proceeding with functional assays . The purification process should be completed quickly, as prolonged procedures may result in activity loss. When evaluating expression systems, researchers should consider that while E. coli typically provides higher yields, expression in V. vulnificus itself might retain more native post-translational modifications that could be important for function.

How should researchers design gene knockout studies to evaluate murG function in vivo?

Designing gene knockout studies for murG in Vibrio vulnificus requires special consideration as this gene is likely essential for bacterial viability. Researchers should implement the following methodological approach:

  • Utilize inducible or conditional knockout systems rather than direct gene deletion. A tetracycline-responsive promoter system can control murG expression levels.

  • Employ complementation approaches where the native gene is deleted only after introducing a plasmid-based copy under inducible control.

  • Consider temperature-sensitive mutants that function normally at permissive temperatures but lose function at restrictive temperatures.

  • Implement CRISPR interference (CRISPRi) to achieve partial knockdown rather than complete knockout, allowing assessment of phenotypes with reduced rather than absent murG function.

  • For in vivo experiments, carefully determine the sample size needed to achieve statistical significance while minimizing animal use, following principles of proper experimental design .

When analyzing results, researchers should evaluate multiple phenotypes including growth rate, cell morphology, antibiotic susceptibility, and virulence in appropriate models. Data should be analyzed using proper statistical methods, with careful attention to choosing the appropriate error term based on the experimental design . Similar to studies of other V. vulnificus virulence factors, researchers should consider both in vitro growth phenotypes and in vivo virulence assays to comprehensively understand murG function .

How should contradictory results in murG functional studies be analyzed and reconciled?

When researchers encounter contradictory results in murG functional studies, they should employ a systematic approach to analysis and reconciliation. First, examine experimental parameters including bacterial strains, growth conditions, and assay methodologies that might account for differences. Second, determine if the contradictions represent true biological variability or experimental artifacts. Third, evaluate whether the contradictions stem from differences in data interpretation rather than the data itself.

When analyzing contradictory results:

  • Compare methodological details carefully, as minor differences in experimental conditions can significantly impact enzyme activity measurements

  • Consider strain-specific variations in the genetic background, as V. vulnificus shows considerable genomic plasticity

  • Evaluate whether contradictory results occur across different research groups or within the same laboratory

  • Analyze raw data using multiple statistical approaches to determine if contradictions arise from analysis choices

A structured approach to contradictory data involves creating a comparison table listing all experimental variables, results, and potential confounding factors. This practice allows researchers to identify patterns that may explain discrepancies. For complex datasets, consider employing multivariate analysis to determine if contradictions arise from interactions between variables rather than single factors.

Similar to how researchers analyze the variability in rtxA1 gene variants in V. vulnificus , contradictory murG results may reflect actual biological differences that should be further investigated rather than dismissed. The holistic vs. analytic thinking approach suggested in cognitive research can be particularly valuable, as it encourages researchers to consider contradictory information as potentially complementary rather than mutually exclusive .

What statistical approaches are most appropriate for analyzing murG expression data across different Vibrio vulnificus strains?

When analyzing murG expression data across different Vibrio vulnificus strains, researchers should select statistical approaches based on the experimental design and data characteristics. For comparing expression levels between clinical and environmental isolates, consider the following statistical framework:

  • For normally distributed data with homogeneous variance:

    • Two-group comparisons: Independent t-tests with appropriate corrections for multiple comparisons (e.g., Bonferroni or FDR)

    • Multi-group comparisons: One-way ANOVA followed by post-hoc tests (Tukey's HSD)

    • Factorial designs: Two-way ANOVA to assess interaction effects between strain type and environmental conditions

  • For non-normally distributed data:

    • Non-parametric alternatives: Mann-Whitney U test (two groups) or Kruskal-Wallis (multiple groups)

    • Consider data transformation (log transformation often works well for gene expression data)

  • For time-course expression studies:

    • Repeated measures ANOVA or mixed-effects models

    • Time series analysis for complex temporal patterns

The selection of statistical methods should align with the experimental design principles outlined in source , which emphasizes the connection between treatment randomization and proper error term selection. When analyzing strain differences, researchers should consider phylogenetic relationships, as V. vulnificus strains cluster into distinct lineages that may influence murG expression patterns . For complex datasets comparing multiple strains under various conditions, multivariate approaches like principal component analysis (PCA) or hierarchical clustering can reveal patterns not apparent in univariate analyses.

How can researchers effectively present complex data on murG variability in scientific publications?

Effectively presenting complex data on murG variability requires thoughtful organization and visualization that highlights key findings while providing necessary context. Following best practices for academic publication:

  • Structure data presentation hierarchically, moving from broad patterns to specific details

  • Use consistent formatting with clear numerical headings for sections and subsections

  • Position tables and figures immediately below the relevant text paragraph, with proper labeling and sequential numbering

  • Include multiple paragraphs per section, each containing 4-5 sentences that build upon previous information to create narrative flow

For tables presenting murG sequence variations:

  • Place table labels ABOVE the table

  • Number tables sequentially (Table 1, Table 2)

  • Reference tables in the text (e.g., "Table 1 shows murG sequence variations across clinical isolates")

  • Provide complete source citation if adapting data from other sources

For figures showing expression levels or functional assays:

  • Place figure captions BELOW the figure

  • Number figures sequentially (Figure 1, Figure 2)

  • Include all necessary methodological details in captions

  • Ensure figures are self-explanatory even when separated from the main text

When presenting comparative data on murG variants, consider using heat maps for sequence conservation, bar graphs for expression levels, and line graphs for enzyme kinetics. Similar to the approach used for presenting rtxA1 variants in V. vulnificus , researchers should organize murG data to facilitate comparison across strains while highlighting correlations with phenotypic characteristics. For complex datasets, consider supplementing traditional presentations with interactive visualizations in online versions of publications.

How can structural biology approaches be applied to understand murG function in Vibrio vulnificus?

Structural biology approaches provide crucial insights into murG function in Vibrio vulnificus by revealing the molecular mechanisms underlying its enzymatic activity. Researchers can employ several complementary methodologies:

  • X-ray crystallography remains the gold standard for obtaining high-resolution structures of murG, revealing active site architecture and substrate binding pockets. When designing crystallization experiments, researchers should screen multiple conditions, focusing on those that have successfully yielded structures of homologous transferases. Purification protocols must prioritize protein homogeneity and stability, often requiring buffer optimization with various additives.

  • Cryo-electron microscopy (cryo-EM) offers advantages for visualizing murG in different conformational states or in complex with other cell wall synthesis machinery. This approach is particularly valuable for capturing transitional states during catalysis.

  • Nuclear Magnetic Resonance (NMR) spectroscopy provides information on protein dynamics and ligand interactions in solution. While challenging for large proteins like murG, selective isotopic labeling strategies can focus on key catalytic regions.

  • Computational approaches including homology modeling and molecular dynamics simulations can complement experimental structures. These in silico methods are particularly valuable for predicting how sequence variations between V. vulnificus strains might impact enzyme function.

When interpreting structural data, researchers should correlate structural features with functional assays to establish structure-function relationships. Similar to approaches used in studying recombination in other V. vulnificus proteins , comparative structural analysis across different bacterial species can highlight conserved catalytic mechanisms versus species-specific adaptations. For maximum impact, structural studies should be integrated with biochemical, genetic, and in vivo approaches to build a comprehensive understanding of murG's role in V. vulnificus cell wall synthesis and pathogenicity.

What approaches are recommended for investigating potential inhibitors of Vibrio vulnificus murG as antimicrobial candidates?

Investigating potential inhibitors of Vibrio vulnificus murG requires a systematic, multidisciplinary approach combining computational screening, biochemical validation, and biological evaluation. Researchers should implement the following methodological framework:

  • Initial screening strategies:

    • Structure-based virtual screening using docking algorithms against murG active site

    • Fragment-based approaches to identify chemical scaffolds with binding potential

    • Repurposing screens of existing antimicrobial compounds or FDA-approved drugs

    • Natural product libraries, particularly from marine sources that may have co-evolved with Vibrio species

  • Biochemical validation:

    • Enzyme inhibition assays using purified recombinant murG to determine IC50 values

    • Binding affinity measurements via isothermal titration calorimetry or surface plasmon resonance

    • Mechanism of inhibition studies to distinguish competitive, non-competitive, or allosteric inhibitors

  • Cellular evaluation:

    • Minimum inhibitory concentration (MIC) determination against multiple V. vulnificus strains

    • Selectivity assessment comparing activity against other bacterial species and mammalian cells

    • Time-kill kinetics to characterize bacteriostatic versus bactericidal activity

  • Target validation:

    • Resistant mutant generation and whole-genome sequencing to confirm murG as the primary target

    • Overexpression studies to determine if increased murG levels confer resistance

    • Metabolic labeling to confirm inhibition of peptidoglycan synthesis in vivo

When designing these experiments, researchers should follow proper experimental design principles with appropriate controls and statistical analysis . The evaluation should include multiple V. vulnificus strains representing different genetic variants, as strain variation could affect inhibitor efficacy . Similar to studies with anti-V. vulnificus immunoglobulins , researchers should assess both in vitro activity and in vivo efficacy in appropriate infection models, measuring parameters such as bacterial load, inflammatory response, and survival rates.

How can researchers use comparative genomics to understand the evolution of murG in Vibrio vulnificus and related species?

Comparative genomics offers powerful approaches to understand murG evolution in Vibrio vulnificus and related species. Researchers should implement a comprehensive analytical framework that includes:

  • Sequence acquisition and alignment:

    • Collect murG sequences from diverse V. vulnificus strains representing different geographical regions, isolation sources (clinical vs. environmental), and biotypes

    • Include murG sequences from related Vibrio species (V. parahaemolyticus, V. cholerae, V. anguillarum)

    • Perform multiple sequence alignment using algorithms optimized for conserved protein-coding genes

    • Create separate alignments for coding sequences and promoter regions to identify regulatory variation

  • Phylogenetic analysis:

    • Construct phylogenetic trees using maximum likelihood or Bayesian methods

    • Evaluate tree topology in comparison to species phylogeny based on housekeeping genes

    • Assess evidence of horizontal gene transfer through incongruence between gene and species trees

    • Calculate evolutionary rates and compare with other essential genes versus virulence factors

  • Detection of selection signatures:

    • Calculate dN/dS ratios across the sequence and within functional domains

    • Implement codon-based tests for positive, negative, and relaxed selection

    • Identify sites under episodic selection using mixed effects models

    • Compare selection patterns with those observed in other cell wall synthesis genes

  • Structural mapping of variation:

    • Map sequence variations onto protein structural models

    • Distinguish variations in catalytic sites versus peripheral regions

    • Correlate structural variations with functional differences if experimental data is available

The analysis should examine whether murG shows recombination patterns similar to those observed in rtxA1 , or if it demonstrates different evolutionary dynamics due to its essential cellular function. When interpreting results, researchers should consider that unlike the highly variable rtxA1 toxin, murG may show more subtle variations that reflect fine-tuning of enzyme efficiency rather than dramatic functional changes. The analysis approach should be similar to that used for studying rtxA gene evolution across Gram-negative pathogens, which revealed different effector domains carried by this class of protein .

What strategies can help overcome challenges in producing active recombinant murG enzyme?

Researchers frequently encounter challenges when producing active recombinant murG enzyme from Vibrio vulnificus. The following methodological approaches can help overcome common obstacles:

  • Addressing protein solubility issues:

    • Optimize induction conditions by reducing temperature (16-18°C) and IPTG concentration (0.1-0.5 mM)

    • Add solubility-enhancing tags (SUMO, MBP, or TrxA) rather than simple His-tags

    • Include membrane mimetics (detergents or lipids) in the buffer to stabilize membrane-associated domains

    • Test different E. coli expression strains (C41/C43 for membrane proteins, Rosetta for rare codons)

    • Consider cell-free expression systems for proteins toxic to host cells

  • Improving protein folding:

    • Co-express with molecular chaperones (GroEL/GroES, DnaK/DnaJ)

    • Include chemical chaperones in the growth medium (4% ethanol, 10% glycerol, or 1M sorbitol)

    • Implement slow dialysis refolding protocols if inclusion bodies cannot be avoided

    • Try pulse-proteolysis approaches to identify stabilizing buffer conditions

  • Maintaining enzyme activity:

    • Add substrate analogs or product mimics during purification to stabilize active conformations

    • Include essential cofactors (divalent cations like Mg²⁺ or Mn²⁺) in all buffers

    • Minimize exposure to oxidizing conditions by including reducing agents (DTT, β-mercaptoethanol)

    • Test activity immediately after purification and optimize storage conditions (glycerol percentage, pH)

When designing experiments to overcome these challenges, researchers should implement proper randomization and replication as outlined in experimental design principles . Tracking protein throughout the purification process using activity assays rather than just SDS-PAGE is critical for identifying steps where activity is lost. Similar to approaches used for other V. vulnificus proteins, researchers might need to consider native purification from V. vulnificus itself if recombinant systems consistently fail to produce active enzyme .

How can researchers troubleshoot inconsistent results in murG activity assays?

When facing inconsistent results in murG activity assays, researchers should implement a systematic troubleshooting approach focusing on methodological variables, reagent quality, and data analysis. The following framework can help identify and resolve sources of variability:

  • Methodological consistency check:

    • Standardize all assay components (buffer composition, pH, salt concentration)

    • Control temperature precisely throughout the assay

    • Establish fixed time points for measurements to ensure linearity

    • Validate enzyme concentration dependency to ensure working in the linear range

    • Implement internal standards or reference compounds in each assay batch

  • Reagent quality assessment:

    • Verify substrate purity using analytical methods (HPLC, mass spectrometry)

    • Prepare fresh substrate solutions before each assay series

    • Test multiple enzyme preparation batches to identify preparation-specific inconsistencies

    • Validate detection reagents with known standards

  • Environmental variables control:

    • Monitor and document laboratory temperature and humidity

    • Use temperature-controlled instrumentation

    • Prepare master mixes to minimize pipetting errors

    • Assign specific researchers to perform critical steps to reduce operator variability

  • Data analysis refinement:

    • Establish clear criteria for identifying and handling outliers

    • Implement appropriate statistical tests based on data distribution

    • Consider using more robust statistical measures (median vs. mean)

    • Calculate and report variability metrics (CV%) for quality control

The experimental design should include appropriate positive and negative controls in each assay plate or batch, following principles of proper experimental design . Similar to approaches used in vaccine development against V. vulnificus, researchers should consider blinding samples during analysis to reduce bias . When evaluating data, researchers should consider whether inconsistencies reflect actual biological variation in murG function across different conditions or experimental artifacts.

What considerations are important when translating in vitro findings about murG to in vivo infection models?

Translating in vitro findings about Vibrio vulnificus murG to in vivo infection models requires careful consideration of multiple factors to ensure biological relevance and interpretability. Researchers should address the following methodological considerations:

  • Model selection and validation:

    • Choose infection models relevant to natural V. vulnificus infection routes (gastric, wound, systemic)

    • Consider host factors known to influence V. vulnificus pathogenicity (iron levels, immune status)

    • Validate that murG expression occurs during in vivo infection using transcriptomics or reporter systems

    • Assess whether in vitro culture conditions used reflect aspects of the in vivo environment

  • Dosage and delivery considerations:

    • Determine appropriate bacterial inoculum based on preliminary dose-finding studies

    • Account for differences in murG expression or activity under in vivo conditions

    • Consider route of administration (intragastric, intraperitoneal, subcutaneous) based on specific research questions

    • Implement proper randomization of experimental animals as detailed in experimental design principles

  • Assessment parameters selection:

    • Define appropriate endpoints (bacterial load, inflammatory markers, survival)

    • Include time-course sampling to capture dynamic processes

    • Consider both local and systemic parameters to assess infection progression

    • Monitor murG expression/activity in recovered bacteria to assess stability in vivo

  • Interpretation framework:

    • Account for host variables that might influence outcomes (genetic background, microbiome)

    • Consider compensatory mechanisms that might mask murG-related phenotypes in vivo

    • Evaluate whether observed phenotypes are specifically related to murG or reflect broader effects

When designing these translational studies, researchers should follow the approach used in studies of anti-V. vulnificus immunoglobulins, measuring parameters such as peritoneal cytokines, blood bacterial load, and survival curves to comprehensively assess infection outcomes . The proper experimental design should include appropriate control groups and statistical methods to account for biological variability in animal models .

How might CRISPR-Cas technologies be applied to study murG function in Vibrio vulnificus?

CRISPR-Cas technologies offer transformative approaches for studying murG function in Vibrio vulnificus, enabling precise genetic manipulations previously challenging in this organism. Researchers can implement several CRISPR-based strategies:

  • Gene expression modulation:

    • CRISPRi (CRISPR interference) using catalytically inactive Cas9 (dCas9) fused to repressors can achieve tunable knockdown of murG expression without complete deletion

    • CRISPRa (CRISPR activation) systems can upregulate murG to assess effects of overexpression

    • Inducible CRISPR systems allow temporal control over murG expression to study its role at different infection stages

  • Precise genome editing:

    • CRISPR-Cas9 with homology-directed repair can introduce specific mutations to investigate structure-function relationships

    • Base editors can create point mutations without double-strand breaks, useful for subtle modifications of catalytic residues

    • Prime editing offers scarless precision editing for complex modifications

  • High-throughput functional genomics:

    • CRISPR screens targeting genes that interact with murG can reveal synthetic lethal relationships

    • Dual-gene CRISPR approaches can identify genetic interactions between murG and virulence factors like rtxA1

    • Single-cell CRISPR methods combined with transcriptomics can reveal phenotypic consequences of murG modulation

  • In vivo applications:

    • CRISPR-delivered murG variants can be introduced directly into animal models to study effects during infection

    • Tissue-specific delivery of CRISPR components can target bacteria in specific host compartments

When designing CRISPR experiments, researchers should follow proper experimental design principles, including appropriate controls and statistical analysis . As with studies of other V. vulnificus factors, CRISPR-based approaches should consider strain variation, as different genetic backgrounds may respond differently to identical modifications . The analysis framework should parallel approaches used for studying gene variants in V. vulnificus, with careful attention to phenotypic characterization both in vitro and in vivo.

What potential exists for developing murG-targeted vaccines against Vibrio vulnificus?

The development of murG-targeted vaccines against Vibrio vulnificus represents an innovative approach that leverages this essential enzyme's potential as an immunogenic target. Researchers exploring this direction should consider the following methodological framework:

  • Antigen design and optimization:

    • Identify immunogenic epitopes within murG using computational prediction and experimental validation

    • Consider whole protein versus peptide-based approaches

    • Evaluate recombinant production of full-length murG versus selected domains

    • Engineer stabilized forms that maintain critical epitopes while enhancing immunogenicity

  • Adjuvant selection and delivery platforms:

    • Test multiple adjuvant formulations to optimize immune response characteristics

    • Evaluate delivery systems including nanoparticles, virus-like particles, and DNA/mRNA platforms

    • Consider mucosal delivery methods given the gastrointestinal route of many V. vulnificus infections

    • Optimize dosing schedules based on durability of immune responses

  • Immunological assessment:

    • Characterize antibody responses (titers, isotypes, neutralizing capacity)

    • Evaluate T-cell responses, particularly for cell-mediated protection

    • Assess mucosal immunity development for gastrointestinal protection

    • Measure cross-reactivity against murG from different V. vulnificus strains and related Vibrio species

  • Protection evaluation:

    • Challenge studies using multiple routes of infection (gastrointestinal, wound, systemic)

    • Determination of correlates of protection

    • Assessment of bacterial clearance, inflammatory markers, and survival rates

    • Long-term protection studies with multiple challenge timepoints

This approach builds upon successful strategies used with chicken egg yolk immunoglobulins (IgYs) against V. vulnificus, which demonstrated significant prophylactic and therapeutic effects against infection . Similar to those studies, researchers should assess multiple parameters including inflammatory response, bacterial load, and survival rates in appropriate animal models. Experimental design should incorporate proper randomization, control groups, and statistical analysis as outlined in experimental design principles . Given the genetic variation observed in V. vulnificus , vaccine development should consider coverage against different strain variants to ensure broad protection.

How might comparative analysis of murG across Vibrio species inform evolutionary adaptation to different ecological niches?

Comparative analysis of murG across Vibrio species offers valuable insights into evolutionary adaptation to diverse ecological niches. Researchers investigating this area should implement a comprehensive analytical framework:

  • Sequence-structure-function relationships:

    • Analyze murG sequence conservation patterns across Vibrio species from different habitats (marine, estuarine, host-associated)

    • Identify amino acid substitutions unique to specific ecological specialists versus generalists

    • Map variations onto structural models to determine their potential functional significance

    • Correlate sequence variations with biochemical parameters (substrate affinity, catalytic efficiency)

  • Expression regulation comparison:

    • Analyze promoter regions to identify regulatory differences between species

    • Compare expression patterns under conditions mimicking different ecological niches

    • Identify regulatory network differences affecting murG expression across species

    • Evaluate whether murG expression shows environment-specific adaptations

  • Evolutionary rate analysis:

    • Calculate evolutionary rates of murG compared to housekeeping genes and virulence factors

    • Identify accelerated evolution in lineages that have undergone niche transitions

    • Test for episodic selection during adaptation to new environments

    • Compare evolutionary patterns of murG with other cell wall synthesis genes

  • Horizontal gene transfer assessment:

    • Evaluate evidence for horizontal transfer of murG or murG domains between Vibrio species

    • Compare with patterns observed in other genes like rtxA that show extensive recombination

    • Identify potential donor-recipient relationships in transfer events

    • Assess whether transfers correlate with ecological shifts

This approach parallels methods used to study rtxA1 gene recombination in V. vulnificus, which identified distinct variants arising through recombination with other sources . Unlike toxin genes that may undergo extensive recombination, murG analysis might reveal more subtle adaptive changes reflecting fine-tuning of cell wall synthesis to specific environmental conditions. Researchers should employ proper experimental design and statistical analysis when testing hypotheses about adaptive significance of observed variations , while considering the possibility that seemingly contradictory results might reflect actual biological complexity rather than experimental artifacts .

How can murG research contribute to comprehensive models of Vibrio vulnificus pathogenesis?

Research on UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase (murG) can significantly enhance our comprehensive understanding of Vibrio vulnificus pathogenesis by connecting fundamental cellular processes to virulence mechanisms. MurG research provides a unique perspective on bacterial fitness and adaptation during infection that complements studies focused on conventional virulence factors.

Integrating murG research into pathogenesis models allows researchers to address how cell wall synthesis coordinates with virulence factor expression during different infection stages. While traditional approaches focus on direct virulence factors like MARTX toxins and hemolysins, murG research illuminates how basic cellular machinery supports pathogen survival and proliferation in hostile host environments. This integration creates a more comprehensive framework for understanding V. vulnificus as an opportunistic pathogen capable of causing severe infections with mortality rates exceeding 50% .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.